KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Thermo Fisher Scientific (TMO) over the last 16 years, with Dec 2024 value amounting to $6.3 billion.

  • Thermo Fisher Scientific's Net Income towards Common Stockholders fell 1.10% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year increase of 7.58%. This contributed to the annual value of $6.3 billion for FY2024, which is 5.67% up from last year.
  • Thermo Fisher Scientific's Net Income towards Common Stockholders amounted to $6.3 billion in FY2024, which was up 5.67% from $6.0 billion recorded in FY2023.
  • Thermo Fisher Scientific's Net Income towards Common Stockholders' 5-year high stood at $7.7 billion during FY2021, with a 5-year trough of $6.0 billion in FY2023.
  • In the last 3 years, Thermo Fisher Scientific's Net Income towards Common Stockholders had a median value of $6.3 billion in 2024 and averaged $6.4 billion.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Net Income towards Common Stockholders soared by 72.48% in 2020, and later fell by 13.74% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Net Income towards Common Stockholders (Yearly) stood at $6.4 billion in 2020, then climbed by 21.18% to $7.7 billion in 2021, then decreased by 10.03% to $7.0 billion in 2022, then fell by 13.74% to $6.0 billion in 2023, then climbed by 5.67% to $6.3 billion in 2024.